Aftercare/continuing care; Acamprosate (Campral®); Sign language services for the deaf and hard of hearing; In-network prescribing entity; No formal relationship with prescribing entity; Breathalyzer or blood alcohol testing; Brief intervention; Cash or self-payment; Cognitive behavioral therapy; Clonidine; Case management service; Comprehensive mental health assessment; Council on Accreditation (COA); Treatment for co-occurring disorders plus serious emotional disturbance (SED) in children; Treatment for co-occurring disorders plus serious mental illness (SMI) in adults; Comprehensive substance use assessment; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; Lofexidine; Naloxone and overdose education








